Cargando…
COVID-19 vaccination in patients receiving dialysis
Patients receiving dialysis are at high risk of contracting SARS-CoV-2 and developing severe COVID-19. Established SARS-CoV-2 vaccination schemes might lack efficacy in these patients and a personalized approach is therefore necessary. Importantly, given the enhanced infection risks associated with...
Autores principales: | Wilde, Benjamin, Korth, Johannes, Jahn, Michael, Kribben, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503726/ https://www.ncbi.nlm.nih.gov/pubmed/34635831 http://dx.doi.org/10.1038/s41581-021-00499-z |
Ejemplares similares
-
SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA
por: Flower, Barnaby, et al.
Publicado: (2020) -
Minimizing the risk of COVID-19 among patients on dialysis
por: Ikizler, T. Alp, et al.
Publicado: (2020) -
Evidence of cell-mediated immune response in kidney transplants with a negative mRNA vaccine antibody response
por: Dolff, Sebastian, et al.
Publicado: (2021) -
Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2021) -
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
por: Korth, Johannes, et al.
Publicado: (2020)